There are currently no known outstanding effects for the The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 80.
80. In regulation 102 (amendment of regulation 110 (revocation, variation and suspension of certificate of registration))—U.K.
(a)for paragraph (2) substitute—
“(2) In paragraph (7) for “established in the European Union” substitute—
“established in—
(a)the United Kingdom; or
(b)in relation to a COR(NI), either the United Kingdom or the European Union,
in accordance with the requirements of these Regulations.”.”;
(b)after paragraph (2) insert—
“(2A) After paragraph (8A) insert—
“(8B) Condition I is that the licensing authority thinks that the revocation, variation or suspension is necessary or expedient in light of the Protocol on Ireland/Northern Ireland in the withdrawal agreement.”.”.
Commencement Information
I1Sch. 2 para. 80 in force at 31.12.2020 immediately before IP completion day, see reg. 1
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
